Presentation
17 March 2023 Microplasma exposure as a novel therapeutic treatment for otitis media demonstrated in a pre-clinical chinchilla model
Author Affiliations +
Abstract
Otitis media (OM) is a common middle ear disease that is treated with antibiotics. However, over-prescription of antibiotics heightens the risk of antibiotic resistance. Here, we report the development and testing of a new cold microplasma (CMP) device to treat OM, and demonstrate the translation for in vivo use in a chinchilla animal model. In vitro nontypeable Haemophilus influenzae bacterial and biofilm samples and ex vivo tissue specimens were evaluated for inactivation and injury. CMP-induced effects on any infectious symptoms (middle ear fluid, biofilms) were longitudinally observed with OCT. This represents the first application of CMP treatments for OM therapy.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Guillermo L. Monroy, Jinhong Kim, Alexander Ho, Andrey Mironov, Farzana R. Zaki, Darold R. Spillman Jr., Gabrielle Choo-Kang, Jungeun Won, Peter P. Sun, Edita Aksamitiene, Marina Marjanovic, Eric J. Chaney, Thanh Huong Nguyen, J. Gary Eden, and Stephen A. Boppart "Microplasma exposure as a novel therapeutic treatment for otitis media demonstrated in a pre-clinical chinchilla model", Proc. SPIE PC12358, Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2023, PC1235809 (17 March 2023); https://doi.org/10.1117/12.2648469
Advertisement
Advertisement
KEYWORDS
Ear

Chemical mechanical planarization

In vitro testing

Optical coherence tomography

Animal model studies

Injuries

Instrument modeling

Back to Top